Nitroglycerin and Sildenafil Drug Interaction

Summary

The combination of nitroglycerin and sildenafil is contraindicated due to the risk of severe, potentially life-threatening hypotension. Both medications cause vasodilation through different mechanisms, and their combined effect can lead to dangerous drops in blood pressure that may result in cardiovascular collapse.

Introduction

Nitroglycerin is a nitrate medication primarily used to treat angina (chest pain) and heart failure by dilating blood vessels and reducing cardiac workload. It belongs to the class of organic nitrates and works by releasing nitric oxide. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor originally developed for pulmonary arterial hypertension and later approved for erectile dysfunction under the brand name Viagra. Both medications have significant cardiovascular effects through their vasodilatory properties.

Mechanism of Interaction

The interaction between nitroglycerin and sildenafil occurs through complementary vasodilatory pathways. Nitroglycerin releases nitric oxide (NO), which activates guanylate cyclase, increasing cyclic GMP levels and causing smooth muscle relaxation in blood vessels. Sildenafil inhibits phosphodiesterase type 5 (PDE5), the enzyme responsible for breaking down cyclic GMP. When used together, nitroglycerin increases cyclic GMP production while sildenafil prevents its breakdown, resulting in dramatically elevated cyclic GMP levels and profound vasodilation that can cause severe hypotension.

Risks and Symptoms

The primary risk of combining nitroglycerin and sildenafil is severe hypotension, which can be life-threatening. Patients may experience dizziness, fainting, cardiovascular collapse, myocardial infarction, or stroke due to inadequate blood flow to vital organs. The hypotensive effect can be prolonged and difficult to reverse with standard treatments. This interaction is particularly dangerous in patients with underlying cardiovascular disease, who may already have compromised cardiac function. The risk persists for at least 24-48 hours after sildenafil administration due to its elimination half-life.

Management and Precautions

The combination of nitroglycerin and sildenafil is absolutely contraindicated. Patients taking any form of nitrates (including nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) should not use sildenafil or other PDE5 inhibitors. Healthcare providers must screen patients for nitrate use before prescribing sildenafil. If a patient on sildenafil experiences chest pain, nitrates should not be administered for at least 24 hours (48 hours for longer-acting PDE5 inhibitors like tadalafil). Alternative treatments for angina, such as calcium channel blockers or beta-blockers, should be considered. Patient education is crucial to ensure understanding of this potentially fatal interaction.

Nitroglycerin interactions with food and lifestyle

Alcohol consumption should be avoided while taking nitroglycerin as it can significantly enhance the blood pressure-lowering effects and increase the risk of dangerous hypotension, dizziness, and fainting. This interaction is well-documented in clinical guidelines and drug databases. Patients should also avoid sudden position changes (standing up quickly) to prevent orthostatic hypotension, especially when starting treatment or increasing doses.

Sildenafil interactions with food and lifestyle

Sildenafil should not be taken with alcohol as it can increase the risk of dangerous drops in blood pressure and may enhance side effects such as dizziness, headache, and heart palpitations. Grapefruit juice may increase sildenafil levels in the blood, potentially leading to increased side effects, and should be avoided or consumed with caution. High-fat meals can delay the absorption of sildenafil and reduce its effectiveness, so it is recommended to take sildenafil on an empty stomach or with a light meal for optimal results.

Specialty: Family Medicine | Last Updated: July 2025

Ready to Streamline Your Chart Prep?
Empathia AI highlights drug risks and flags interactions right inside your intake summaries—before or during the visit. Trusted by thousands of clinicians.
@2025 Empathia AI, Inc. All rights reserved.